NADPH oxidases are a family of membrane oxidoreductases that has been widely acknowledged as a ‘professional’ source of ROS (mainly, superoxide anion) in cardiovascular pathologies [141] underlying the oxidative stress-mediated endothelial dysfunction, both in systemic circulation and microvascular beds [142,143,144]. The gene discussed is FMO5; the disease is endothelial dysfunction.